stars 1 stars 2 stars 3

ANGANY is a private, early clinical stage pharmaceutical company, based in Lévis, QC, Canada. ANGANY has tackled the specific challenges of allergy to invent a novel class of biologics. ANGANY has developed an exclusive therapeutic platform based on synthetic biology: the eBioparticle ™, a self-adjuvant vector bringing novel features of safety and potent immunomodulation to thwart allergy.

ANGANY Questions

The ANGANY annual revenue was $2 million in 2026.

Christine Guillen is the CEO and PDG of ANGANY.

11 people are employed at ANGANY.

ANGANY is based in Québec, Québec.

The NAICS codes for ANGANY are [32541, 3254, 32, 325].

The SIC codes for ANGANY are [28, 283].

Top ANGANY Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users